Integrin Antagonists and Other Low Molecular Weight Compounds as Inhibitors of Angiogenesis: New Drugs in Cancer Therapy

This publication has 23 references indexed in Scilit:

• Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide
  Life Sciences, 1995
• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994
• Requirement of Vascular Integrin α _v β ₃ for Angiogenesis
  Science, 1994
• The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
  Nature, 1994
• Peptidmimetica für Rezeptorliganden – Entdeckung, Entwicklung und medizinische Perspektiven
  Angewandte Chemie, 1993
• Irsogladine is a potent inhibitor of angiogenesis
  FEBS Letters, 1993
• „Dynamischer Zwang”︁, eine Hilfe für das Verständnis der Aktivität und Selektivität von RGD(Arg‐Gly‐Asp)‐Peptiden
  Angewandte Chemie, 1992
• Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor
  Biochemical and Biophysical Research Communications, 1991
• Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1
  FEBS Letters, 1991
• Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
  Nature, 1990